Ankylosing spondylitis monocytes show upregulation of proteins involved in inflammation and the ubiquitin proteasome pathway

Annals of the Rheumatic Diseases

Volumn 68, Issue 10, 2009, Pages 1626-1632

  Wright, C ^a   Edelmann, M ^a   DiGleria, K ^a   Kollnberger, S ^a   Kramer, H ^a   McGowan, S ^a   McHugh, K ^a   Taylor, S ^a   Kessler, B ^a   Bowness, P ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; EPITOPE; HLA B27 ANTIGEN; INTEGRIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEASOME; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ANTIBODY; UBIQUITIN; VASCULOTROPIN;

ADULT; AGED; AMINO ACID SEQUENCE; ANKYLOSING SPONDYLITIS; ARTICLE; BETA CHAIN; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; ENDOPLASMIC RETICULUM STRESS; EXTRAVASATION; FEMALE; GENE EXPRESSION PROFILING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IN VITRO STUDY; MALE; MONOCYTE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION;

ADULT; AGED; ARTHRITIS, RHEUMATOID; BLOOD PROTEINS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HLA-B27 ANTIGEN; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; MONOCYTES; MUSCLE PROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEOMICS; SPONDYLITIS, ANKYLOSING; UBIQUITIN; UP-REGULATION;

EID: 70349386176     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2008.097204     Document Type: Article

References (41)

1. Brown M, Bunce M, Calin A, et al. HLA-B associations of HLA-B27 negative ankylosing spondylitis: comment on the article by Yamaguchi et al. Arthritis Rheum 1996;39:1768-1769
2. Allen RL, Bowness P, McMichael A. The role of HLA-B27 in spondyloarthritis. Immunogenetics 1999;50:220-227
3. May E, Dorris ML, Satumtira N, et al. CD8αβ T cells are not essential to the pathogenesis of arthritis or colitis in HLA-B27 transgenic rats. J Immunol 2003;170:1099-1105 (Pubitemid 36070566)
4. Allen RL, Raine T, Haude A, et al. Leucocyte receptor complex-encoded immunomodulatory receptors show differing specificity for alternative HLA-B27 structures. J Immunol 2001;167:5543-5547 (Pubitemid 33062742)
5. Kollnberger S, Sun M-Y, Bird L, et al. Cell surface expression and immune receptor recognition of free HLA B27 heavy chains. Arthritis Rheum 2002;46:2972-2982
6. Turner MJ, Delay ML, Bai S, et al. HLA-B27 up-regulation causes accumulation of misfolded heavy chains and correlates with the magnitude of the unfolded protein response in transgenic rats: Implications for the pathogenesis of spondylarthritis-like disease. Arthritis Rheum 2007;56:215-223 (Pubitemid 46106195)
7. Wellcome Trust Case Control Consortium. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 2007;39:1329-1337
8. Schulz M, Dotzlaw H, Mikkat S, et al. Proteomic analysis of peripheral blood mononuclear cells: selective protein processing observed in patients with rheumatoid arthritis. J Proteome Res 2007;6:3752-3759 (Pubitemid 47522763)
9. Liu J, Zhu P, Peng J, et al. Identification of disease-associated proteins by proteomic approach in ankylosing spondylitis. Biochem Biophys Res Commun 2007;357:531-536 (Pubitemid 46603163)
10. Gu J, Marker-Hermann E, Baeten D, et al. A 588-gene microarray analysis of the peripheral blood mononuclear cells of spondyloarthropathy patients. Rheumatology (Oxford) 2002;41:759-766 (Pubitemid 34822958)
11. De Rycke L, Vandooren B, Kruithof E, et al. Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy. Arthritis Rheum 2005;52:2146-2158 (Pubitemid 40994338)
12. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-368
13. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-324
14. Hesse GW, Hofstein R, Shashoua VE. Protein release from hippocampus in vitro. Brain Res 1984;305:61-66
15. Altun M, Edstrom E, Spooner E, et al. Iron load and redox stress in skeletal muscle of aged rats. Muscle Nerve 2007;36:223-233 (Pubitemid 47221860)
16. Mortz E, Krogh TN, Vorum H, et al. Improved silver staining protocols for high sensitivity protein identification using matrix-assisted laser desorption/ionization-time of flight analysis. Proteomics 2001;1:1359-1363 (Pubitemid 33587891)
17. Batycka M, Inglis NF, Cook K, et al. Ultra-fast tandem mass spectrometry scanning combined with monolithic column liquid chromatography increases throughput in proteomic analysis. Rapid Commun Mass Spectrom 2006;20:2074-2080 (Pubitemid 44049032)
18. Guillemin I, Becker M, Ociepka K, et al. A subcellular prefractionation protocol for minute amounts of mammalian cell cultures and tissue. Proteomics 2005;5:35-45. (Pubitemid 40189635)
19. Huet S, Nixon DF, Rothbard JB, et al. Structural homologies between two HLA B27- restricted peptides suggest residues important for interaction with HLA B27. Int Immunol 1990;2:311-316 (Pubitemid 20150936)
20. Kuon W, Holzhutter HG, Appel H, et al. Identification of HLA-B27-restricted peptides from the Chlamydia trachomatis proteome with possible relevance to HLA-B27- associated diseases. J Immunol 2001;167:4738-4746 (Pubitemid 32954356)
21. Groettrup M, Soza A, Eggers M, et al. A role for the proteasome regulator PA28a in antigen presentation. Nature 1996;381:166-168 (Pubitemid 26137966)
22. Iwata T, Sato S, Jimenez J, et al. Osmotic response element is required for the induction of aldose reductase by tumor necrosis factor-alpha. J Biol Chem 1999;274:7993-8001. (Pubitemid 129518194)
23. Banno T, Gazel A, Blumenberg M. Effects of tumor necrosis factor-alpha (TNF alpha) in epidermal keratinocytes revealed using global transcriptional profiling. J Biol Chem 2004;279:32633-32642 (Pubitemid 39014721)
24. Zhu GH, Schwartz EL. Expression of the angiogenic factor thymidine phosphorylase in THP-1 monocytes: induction by autocrine tumor necrosis factor-alpha and inhibition by aspirin. Mol Pharmacol 2003;64:1251-1258
25. Matikainen S, Siren J, Tissari J, et al. Tumor necrosis factor alpha enhances influenza A virus-induced expression of antiviral cytokines by activating RIG-I gene expression. J Virol 2006;80:3515-3522
26. Drost EM, MacNee W. Potential role of IL-8, platelet-activating factor and TNF-alpha in the sequestration of neutrophils in the lung: effects on neutrophil deformability, adhesion receptor expression, and chemotaxis. Eur J Immunol 2002;32:393-403. (Pubitemid 34173331)
27. Roy A, Fung YK, Liu X, et al. Up-regulation of microglial CD11b expression by nitric oxide. J Biol Chem 2006;281:14971-14980 (Pubitemid 43855201)
28. Feinberg MW, Jain MK, Werner F, et al. Transforming growth factor-beta 1 inhibits cytokine-mediated induction of human metalloelastase in macrophages. J Biol Chem 2000;275:25766-25773 (Pubitemid 30687081)
29. Geraghty P, Greene CM, O'Mahony M, et al. Secretory leucocyte protease inhibitor inhibits interferon-gamma-induced cathepsin S expression. J Biol Chem 2007;282:33389-33395 (Pubitemid 350159551)
30. Mayo MW, Madrid LV, Westerheide SD, et al. PTEN blocks tumor necrosis factorinduced NF-kappa B-dependent transcription by inhibiting the transactivation potential of the p65 subunit. J Biol Chem 2002;277:11116-11125
31. Salvucci O, Kolb JP, Dugas B, et al. The induction of nitric oxide by interleukin-12 and tumor necrosis factor-alpha in human natural killer cells: relationship with the regulation of lytic activity. Blood 1998;92:2093-2102 (Pubitemid 28446699)
32. Koide M, Kawahara Y, Tsuda T, et al. Cytokine-induced expression of an inducible type of nitric oxide synthase gene in cultured vascular smooth muscle cells. FEBS Lett 1993;318:213-217 (Pubitemid 23071738)
33. Han B, Mura M, Andrade CF, et al. TNF alpha-induced long pentraxin PTX3 expression in human lung epithelial cells via JNK. J Immunol 2005;175:8303-8311 (Pubitemid 41798396)
34. Xu K, Geczy CL. IFN-gamma and TNF regulate macrophage expression of the chemotactic S100 protein S100A8. J Immunol 2000;164:4916-4923 (Pubitemid 30238097)
35. Hu X, Park-Min KH, Ho HH, et al. IFN-gamma-primed macrophages exhibit increased CCR2-dependent migration and altered IFN-gamma responses mediated by Stat1. J Immunol 2005;175:3637-3647 (Pubitemid 41292023)
36. Sappington PL, Han X, Yang R, et al. Ethyl pyruvate ameliorates intestinal epithelial barrier dysfunction in endotoxemic mice and immunostimulated caco-2 enterocytic monolayers. J Pharmacol Exp Ther 2003;304:464-476 (Pubitemid 36013435)
37. Smith JA, Barnes MD, Hong D, et al. Gene expression analysis of macrophages derived from ankylosing spondylitis patients reveals interferon-gamma dysregulation. Arthritis Rheum 2008;58:1640-1649 (Pubitemid 351847516)
38. Voeten JT, Bestebroer TM, Nieuwkoop NJ, et al. Antigenic drift in the influenza A virus (H3N2) nucleoprotein and escape from recognition by cytotoxic T lymphocytes. J Virol 2000;74:6800-6807
39. Butt C, Lim S, Greenwood C, et al. VEGF, FGF1, FGF2 and EGF gene polymorphisms and psoriatic arthritis. BMC Musculoskelet Disord 2007;8:1. (Pubitemid 46169616)
40. Seo JS, Lee SS, Kim SI, et al. Influence of VEGF gene polymorphisms on the severity of ankylosing spondylitis. Rheumatology (Oxford) 2005;44:1299-1302 (Pubitemid 41487965)
41. Kessler BM, Fortunati E, Melis M, et al. Proteome changes induced by knock-down of the deubiquitylating enzyme HAUSP/USP7. J Proteome Res 2007;6:4163-4172 (Pubitemid 350158494)